Related references
Note: Only part of the references are listed.A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia
Shinji Honda et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Lovastatin protects against cisplatin-induced hearing loss in mice
Katharine Fernandez et al.
HEARING RESEARCH (2020)
An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity
K. Fernandez et al.
HEARING RESEARCH (2019)
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S. Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection
Anna Hucke et al.
ARCHIVES OF TOXICOLOGY (2019)
Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis
Fei Zhang et al.
JOURNAL OF CANCER (2019)
Applying US national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions
Dawn Konrad-Martin et al.
INTERNATIONAL JOURNAL OF AUDIOLOGY (2018)
Long term platinum-induced ototoxicity in pediatric patients
Sofia Waissbluth et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2018)
Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients
Sofia Waissbluth et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2018)
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
Sandeep Sheth et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Cisplatin is retained in the cochlea indefinitely following chemotherapy
Andrew M. Breglio et al.
NATURE COMMUNICATIONS (2017)
Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life
Mans Stefansson et al.
ACTA ONCOLOGICA (2016)
Audiological Monitoring in Children Treated with Platinum Chemotherapy
A. R. Fetoni et al.
AUDIOLOGY AND NEURO-OTOLOGY (2016)
Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study
Eva Clemens et al.
EUROPEAN JOURNAL OF CANCER (2016)
In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity
A. Roldan-Fidalgo et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2016)
Sudden hearing loss due to oxaliplatin use in a patient with colon cancer
M. Guven Guvenc et al.
JOURNAL OF CHEMOTHERAPY (2016)
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
Robert D. Frisina et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations
Anna Hucke et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
Jing Yu et al.
MEDICINE (2015)
Human OCT2 variant c.808G > T confers protection effect against cisplatin-induced ototoxicity
Claudia Lanvers-Kaminsky et al.
PHARMACOGENOMICS (2015)
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
Hyun Sun Woo et al.
CANCER RESEARCH AND TREATMENT (2015)
Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures
Pascal Dammeyer et al.
ACTA OTO-LARYNGOLOGICA (2014)
Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines
Jeongho Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer
Masahiro Uchida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Concordance Between the Chang and the International Society of Pediatric Oncology (SIOP) Ototoxicity Grading Scales in Patients Treated With Cisplatin for Medulloblastoma
Johnnie K. Bass et al.
PEDIATRIC BLOOD & CANCER (2014)
Incidence of Platinum-Induced Ototoxicity in Pediatric Patients in Quebec
Emilia Peleva et al.
PEDIATRIC BLOOD & CANCER (2014)
Oxaliplatin and ototoxicity: is it really safe for hearing?
Salim Yuce et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2014)
A case of oxaliplatin-induced immune-mediated thrombocytopenia
Seong Eun Suh et al.
BLOOD RESEARCH (2014)
Sound preconditioning therapy inhibits ototoxic hearing loss in mice
Soumen Roy et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Understanding platinum-induced ototoxicity
Thorsten Langer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients
Alexandra Nitz et al.
ONCOLOGY LETTERS (2013)
Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
Jochen Schacht et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2012)
Carboplatin-Associated Ototoxicity in Children With Retinoblastoma
Ibrahim Qaddoumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
Antonio Rossi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients
Allison Yancey et al.
PEDIATRIC BLOOD & CANCER (2012)
Role of organic cation transporters in drug-induced toxicity
Giuliano Ciarimboli
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
A Phase III Randomized Trial of Gemcitabine-Oxaliplatin versus Carboplatin-Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
Charles H. Weissman et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer
Xiao-Dong Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Unilateral Hearing Loss Is Associated With Worse Speech-Language Scores in Children
Judith E. C. Lieu et al.
PEDIATRICS (2010)
Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
Victoria Hellberg et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Can carboplatin replace cisplatin for intraperitoneal use?
K. Fujiwara
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration
D. Esteban-Fernandez et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2008)
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin:: A study of the arbeitsgemeinschaft internistische onkologie
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens
Jennifer B. Dean et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
The application of inductively coupled plasma mass spectrometry in clinical pharmacological oncology research
Elke E. M. Brouwers et al.
MASS SPECTROMETRY REVIEWS (2008)
Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: Report from the Children's Oncology Group
James G. Gurney et al.
PEDIATRICS (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig
Goeran Laurell et al.
AUDIOLOGY AND NEURO-OTOLOGY (2007)
The age at which young deaf children receive cochlear implants and their vocabulary and speech-production growth: Is there an added value for early implantation?
Carol McDonald Connor et al.
EAR AND HEARING (2006)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Oxaliplatin-related neurotoxicity: How and why?
Lara Maria Pasetto et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin
BR Curtis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Relationship between cisplatin administration and the development of ototoxicity
JM Rademaker-Lakhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer
C. L. Zuur et al.
AUDIOLOGY AND NEURO-OTOLOGY (2006)
Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up
Alberto Pietrangeli et al.
EUROPEAN NEUROLOGY (2006)
Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distorsion product otoacoustic emission
K. Biro et al.
ONCOLOGY (2006)
Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate
WT Choe et al.
OTOLOGY & NEUROTOLOGY (2004)
Platinum compound-related ototoxicity in children - Long-term follow-up reveals continuous worsening of hearing loss
P Bertolini et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures
E Gamelin et al.
SEMINARS IN ONCOLOGY (2002)
Oxaliplatin:: available data in non-colorectal gastrointestinal malignancies
Y Bécouarn et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Relationships among speech perception, production, language, hearing loss, and age in children with impaired hearing
PJ Blamey et al.
JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH (2001)
Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants
MA Lopez-Ganzalez et al.
JOURNAL OF PINEAL RESEARCH (2000)
Share Paper
